Is this you? Create Your Porfile
Avatar

Gerhard Fries

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Gerhard Fries is active.

Explore More

Publication

Featured researches published by Gerhard Fries.

Archive | 1999

Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis

Wolfgang Wohlrab; Reinhard Neubert; Christoph Huschka; Peter-Jürgen Müller; Jörg-Herman Ozegowski; Dieter Koegst; Gerhard Fries

Archive | 1991

Mittel zur behandlung von hauterkrankungen

Wolfgang Wohlrab; Hans-Werner Dr Hoefer; Katrin Dr Wellner; Reinhard Neubert; Walter Prof Dr Fuerst; Lothar Dr Rer Nat Luecke; Gerhard Fries; Gunter Dr Voigt

Archive | 1999

Hyaluronate lyase used for promoting penetration in topical agents

Wolfgang Wohlrab; Reinhard Neubert; Christoph Huschka; Peter-Jürgen Müller; Jörg-Herman Ozegowski; Dieter Koegst; Gerhard Fries

Archive | 1991

Skin diseases treatment agent - contains 2-hydroxy-5-methyl-lauro-phenone oxime combined with natural hydrating agents, moisturisers and/or penetration promoters

Wolfgang Wohlrab; Hans-Werner Dr Hoefer; Katrin Dr Wellner; Reinhard Neubert; Walter Prof Dr Fuerst; Lothar Dr Rer Nat Luecke; Gerhard Fries; Gunter Dr Voigt

Archive | 2002

Medicament containing an effector of the glutathione metabolism together with

Michael Taeger; Siegfried Ansorge; Gerhard Fries; Dieter Koegst

Archive | 2001

g(a)-lipoic acid for treating diabetes mellitus

Rudolf-Giesbert Dr Alken; Dieter Koegst; Gerhard Fries

Archive | 1999

Treatment of lipid metabolic disorders using 5-(1,2-dithiolan-3-yl) valeric acid (alpha-lipoic acid) or its physiologically compatible salts

Rudolf-Giesbert Dr Alken; Gerhard Fries; Dieter Koegst

Archive | 1992

Use of 5-(1,2-dithiolan-3-yl)valeric acid (alpha-lipoic acid) or its physiologically acceptable salts for treating lipid metabolism disorders

Lothar Lücke; Gerhard Fries; Gunter Dr Voigt; Reinhard Neubert; Walter Fürst; Jürgen Dr. Slapke; Tankred Schewe

Archive | 2004

COMPOSITION AND METHODS FOR PROVIDING OPTIMUM BIOAVAILABILITY OF THE ACTIVE INGREDIENT 2-HYDROXY-5-METHYLLAUROPHENOXIME (HMLO)

Siegfried Ansorge; Dieter Koegst; Michael Taeger; Gerhard Fries

Archive | 2004

Use Of At Least One Effector Of Glutathione Metabolism Together With Alpha-Lipoic Acid For The Treatment Of Chronically Obstructive Lung Diseases

Siegfried Ansorge; Dieter Koegst; Michael Täger; Gerhard Fries

Explore More

Collaboration

Dive into the Gerhard Fries's collaboration.

Top Co-Authors
Avatar

Siegfried Ansorge

Otto-von-Guericke University Magdeburg

View shared research outputs
Top Co-Authors
Avatar

Reinhard Neubert

Merck

View shared research outputs
Top Co-Authors
Avatar

Wolfgang Wohlrab

Merck

View shared research outputs
Top Co-Authors
Avatar

Michael Täger

Otto-von-Guericke University Magdeburg

View shared research outputs
Top Co-Authors
Avatar

Tankred Schewe

Humboldt State University

View shared research outputs
Top Co-Authors
Avatar

Jens Hollmann

Braunschweig University of Technology

View shared research outputs
Top Co-Authors
Avatar

Joachim Klein

Braunschweig University of Technology

View shared research outputs
Top Co-Authors
Avatar

Juergen Dr Slapke

Humboldt University of Berlin

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge